"We are excited to be an integral part of the medical community in Las Vegas, Nevada! Founded by Dr. Douglas Fife in 2009, we are a dedicated team of Las Vegas dermatology doctors and surgeons, seeking to provide exceptional care and state-of-the-art treatment to every patient, giving them more confidence to face the future. We pride ourselves in being a resource for a wide range of dermatologic procedures, from skin cancer surgery to aesthetic laser procedures."

During the past decade, Vivida Dermatology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vivida Dermatology" are "Plaque Psoriasis" (3 trials), "Alopecia Areata" (2 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Vivida Dermatology" in a lesser frequency.

Most popular intervention types in "Vivida Dermatology" are "Drug" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "JNJ-77242113" (2 trials), "ABP 501" (1 trials), "Abrocitinib 200 mg" (1 trials), "Adalimumab" (1 trials) and "CTP-543" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vivida Dermatology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Vivida Dermatology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Vivida Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vivida Dermatology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".